Amantadine for Dyskinesias in Parkinson's Disease: A Randomized Controlled Trial - Concepedia

Concepedia

Publication | Open Access

Amantadine for Dyskinesias in Parkinson's Disease: A Randomized Controlled Trial

DOI Full Paper Access

139

Citations

23

References

2010

Year

Hideyuki Sawada, Tomoko Oeda, Sadako Kuno, Masahiro Nomoto, Kenji Yamamoto, Mitsutoshi Yamamoto, Kinya Hisanaga, Takashi Kawamura

Abstract

UMIN Clinical Trial Registry UMIN000000780.

References

	Year	Citations
The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials David Moher, Kenneth F. Schulz, Douglas G. Altman BMC Medical Research Methodology	2001	2.7K
Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease Alim Louis Benabid, Stéphan Chabardès, John Mitrofanis, The Lancet Neurology Stimulation DeviceDeep Brain StimulationNeurophysiologyNeuroanatomyMedicine	2008	1.3K
Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease. M. C. de Rijk, Christophe Tzourio, Monique M.B. Breteler, Journal of Neurology Neurosurgery & Psychiatry	1997	832
The origins of two-state spontaneous membrane potential fluctuations of neostriatal spiny neurons Yasuo Kawaguchi Journal of Neuroscience Synaptic TransmissionNeurotransmitterUp StateNeurotransmissionCellular Neurobiology	1996	791
Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats Manolo Carta, Thomas Carlsson, Deniz Kirik, Brain NeurotransmitterL-dopa-induced DyskinesiaSpared Serotonin Innervation5-Ht TerminalsParkinsonian Rats	2007	613
Parkinson's Disease Society Brain Bank, London: overview and research. S. E. Daniel, Andrew J. Lees PubMed Tissue HandlingNeurological DisorderCorticobasal DegenerationClinical NeurologyDiagnosis	1993	603
Impact of the motor complications of Parkinson's disease on the quality of life Stéphane Chapuis, Lemlih Ouchchane, O Metz, Movement Disorders	2004	516
Amantadine as treatment for dyskinesias and motor fluctuations in Parkinson's disease Leonard Verhagen Metman, Paolo Del Dotto, Pepijn van den Munckhof, Neurology	1998	511
Effects of the 1-amino-adamantanes at the MK-801-binding site of the NMDA-receptor-gated ion channel: a human postmortem brain study Johannes Kornhuber, Joachim Bormann, Marianne Hübers, European Journal of Pharmacology Molecular Pharmacology Nmda-receptor-gated Ion ChannelBiochemistryNeurophysiologyFunctional SelectivityNeurotransmitter	1991	306
Up and Down States in Striatal Medium Spiny Neurons Simultaneously Recorded with Spontaneous Activity in Fast-Spiking Interneurons Studied in Cortex–Striatum–Substantia Nigra Organotypic Cultures Dietmar Plenz, S.T. Kitai Journal of Neuroscience	1998	284

Page 1